Aclaris Therapeutics, Inc.

NASDAQ:ACRS

1.17 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 2.7662.39817.579.2821.8692.5287.75319.0181.5281.4531.5011.6591.8241.7771.581.4492.0461.4071.0950.9835.8655.0413.6691.6283.6761.1180.9990.68400000000000000
Cost of Revenue 1.9091.846.4280.8481.5921.8691.5148.2231.0681.1551.1491.0991.2631.2021.2861.1891.3891.2691.0280.8262.7032.7773.5091.1931.1810.9670.7540.45300000000000000
Gross Profit 0.8570.55811.1428.4340.2770.6596.23910.7950.460.2980.3520.560.5610.5750.2940.260.6570.1380.0670.1573.1622.2640.160.4352.4950.1510.2450.23100000000000000
Gross Profit Ratio 0.310.2330.6340.9090.1480.2610.8050.5680.3010.2050.2350.3380.3080.3240.1860.1790.3210.0980.0610.160.5390.4490.0440.2670.6790.1350.2450.33800000000000000
Reseach & Development Expenses 8.7599.84526.64623.87625.27522.58721.07223.65618.77914.30614.10213.9767.8977.8388.9566.8666.4669.44411.5416.18317.62219.91919.53715.93113.98413.60613.18910.8647.9657.7726.9437.1629.8369.5352.4029.4081.7931.7372.0542.0971.1781.178
General & Administrative Expenses 4.7526.8448.2147.0918.3178.797.1465.8136.0756.0996.9435.9795.874.8274.8983.8595.5726.25.7656.1747.998.1936.6946.5746.6216.2612.4988.1237.335.1584.6843.653.1533.6042.41.2320.8030.8920.5480.5650.4570.457
Selling & Marketing Expenses -0.1-2.5-4.91800000000000000.0270.2570.0440.1127.1779.82812.96711.3812.36811.2336.5863.5572.1881.438000000000000
SG&A 4.6524.3448.2147.0918.3178.797.1465.8136.0756.0996.9435.9795.874.8274.8983.8595.5726.25.8096.28615.16718.02119.66117.95418.98917.49312.4988.1237.335.1584.6843.653.1533.6042.41.2320.8030.8920.5480.5650.4570.457
Other Expenses 1.8681.992.1899.0442.2461.7581.4440.9220.4620.1180.089-0.851-0.155-0.225-0.219-0.194-0.1890.178-1.895-0.274-0.085-0.230.4870.710.760.7190.6780.5640.4570.3710.1520.1180.1180.100.0080.0020.0060000
Operating Expenses 13.41114.18934.8640.01133.59231.37728.21829.46924.85420.40521.04519.95513.76712.66513.85410.72512.03815.64417.34922.46934.44939.59939.19833.88532.97331.09925.68718.98715.29512.9311.62710.81212.98913.1394.80210.642.5962.6292.6022.6621.6341.634
Operating Income -12.554-13.631-4.047-31.577-31.815-30.718-21.979-18.674-24.394-20.107-22.893-20.295-18.006-28.529-13.56-10.465-11.381-15.506-17.282-22.864-49.791-37.335-39.038-33.45-31.978-30.948-25.442-18.756-15.295-12.93-11.627-10.812-12.989-13.139-4.802-10.64-2.596-2.629-2.602-2.662-1.635-1.635
Operating Income Ratio -4.539-5.684-0.23-3.402-17.022-12.151-2.835-0.982-15.965-13.838-15.252-12.233-9.872-16.055-8.582-7.222-5.563-11.021-15.783-23.259-8.49-7.406-10.64-20.547-8.699-27.682-25.467-27.42100000000000000
Total Other Income Expenses Net 1.568-3.3121.862.3163.7462.558-5.656-1.2783.8621.318-2.111-1.751-4.955-16.664-0.219-0.194-0.1890.178-1.895-0.826-18.589-0.230.4870.71-0.740.7190.6780.5640.4570.3710.1520.1180.1180.10.0880.0070.0020.0060.0050.0050.0030.003
Income Before Tax -10.986-16.941-1.858-29.261-29.569-28.16-27.635-19.952-20.532-18.789-22.804-21.146-18.161-28.754-13.779-10.659-11.57-15.328-19.177-23.138-49.876-37.565-38.551-32.74-31.218-30.229-24.764-18.192-14.838-12.559-11.475-10.694-12.871-13.039-4.714-10.633-2.594-2.623-2.597-2.657-1.632-1.632
Income Before Tax Ratio -3.972-7.065-0.106-3.152-15.821-11.139-3.564-1.049-13.437-12.931-15.193-12.746-9.957-16.181-8.721-7.356-5.655-10.894-17.513-23.538-8.504-7.452-10.507-20.111-8.492-27.038-24.789-26.59600000000000000
Income Tax Expense 00.2-0.367-0.219-1.5-1.7585.6561.278-3.862-1.3182.0030.94.816.439-0.182-0.5910.027-0.318-32.18132.73318.5040-0.95801.50-1.83000-0.04000-0.033-0.03200000.4570.457
Net Income -10.986-16.941-1.491-29.261-29.569-26.402-33.291-21.23-16.67-17.471-22.804-21.146-18.161-28.754-13.173-10.659-11.597-15.586-18.594-55.319-49.876-37.565-38.551-32.74-31.218-30.229-22.934-18.192-14.838-12.559-11.475-10.694-12.871-13.039-4.714-10.633-2.594-2.623-2.597-2.657-2.088-2.088
Net Income Ratio -3.972-7.065-0.085-3.152-15.821-10.444-4.294-1.116-10.91-12.024-15.193-12.746-9.957-16.181-8.337-7.356-5.668-11.077-16.981-56.276-8.504-7.452-10.507-20.111-8.492-27.038-22.957-26.59600000000000000
EPS -0.15-0.24-0.021-0.41-0.42-0.39-0.5-0.32-0.25-0.28-0.37-0.35-0.34-0.57-0.3-0.25-0.28-0.37-0.45-1.34-1.21-0.91-0.99-1.06-1.01-0.98-0.74-0.63-0.56-0.48-0.49-0.5-0.62-0.65-0.26-0.55-0.13-0.25-0.24-0.25-1.25-1.25
EPS Diluted -0.15-0.24-0.021-0.41-0.42-0.39-0.5-0.32-0.25-0.28-0.37-0.35-0.34-0.57-0.3-0.25-0.28-0.37-0.45-1.34-1.21-0.91-0.99-1.06-1.01-0.98-0.74-0.63-0.56-0.48-0.49-0.5-0.62-0.65-0.26-0.55-0.13-0.25-0.24-0.25-1.25-1.25
EBITDA -12.354-13.388-43.161-31.577-34.597-31.32-14.879-16.281-27.588-21.099-18.493-18.304-8.1594.637-13.56-10.465-10.775-15.506-17.282-20.128-10.552-35.109-39.038-33.066-28.663-30.726-25.442-18.64-15.24-12.88-11.627-10.78-12.962-13.118-4.802-10.64-2.574-2.626-2.599-2.659-1.632-1.632
EBITDA Ratio -4.466-5.583-2.457-3.402-18.511-12.389-1.919-0.856-18.055-14.521-12.32-11.033-4.4732.609-8.582-7.222-5.266-11.021-15.783-20.476-1.799-6.965-10.64-20.311-7.797-27.483-25.467-27.25100000000000000